Gerhartz HH - Search Results

1

The use of dose-intensified chemotherapy in the treatment of metastatic nonseminomatous testicular germ cell tumors. German Testicular Cancer Study Group.

Bokemeyer C, Harstrick A, Beyer J, Metzner B, Rüther U, Hartmann JT, Holstein K, Derigs HG, de Wit R, Casper J, Schöffski P, Kührer I, Illiger HJ, Kempf B, Reichle A, Föller A, Hossfeld DK, Fischer JT, Berdel WE, Gerhartz HH, Kirchner H, Pflüger KH, Ostermann H, Kanz L, Schmoll HJ. Bokemeyer C, et al. Among authors: gerhartz hh. Semin Oncol. 1998 Apr;25(2 Suppl 4):24-32; discussion 45-8. Semin Oncol. 1998. PMID: 9578059 Review.

2

Prognosis of high dose chemotherapy/autologous bone marrow transplantation candidates not receiving this treatment after failure of primary therapy of Hodgkin's disease.

Fuchs R, Löffler M, Pfreundschuh M, Dölken G, Gerhartz H, Hagen-Aukamp U, Hiller E, Petsch S, Pflüger KH, Rühl U, et al. Fuchs R, et al. Leuk Lymphoma. 1994 Jun;14(1-2):79-89. doi: 10.3109/10428199409049653. Leuk Lymphoma. 1994. PMID: 7522721 Clinical Trial.

3

[Recurrence of Hodgkin's disease after advanced primary stages. German Hodgkin's Study Group].

Fuchs R, Löffler M, Pfreundschuh M, Dölken G, Gerhartz H, Hagen-Aukamp U, Hiller E, Petsch S, Pflüger KH, Rühl U, et al. Fuchs R, et al. Med Klin (Munich). 1992 Nov 15;87(11):555-62. Med Klin (Munich). 1992. PMID: 1281905 Clinical Trial. German.

4

Cooperative trials of Hodgkin's lymphoma in the Federal Republic of Germany.

Diehl V, Pfreundschuh M, Löffler M, Rühl U, Hiller E, Gerhartz H, Kirchner H. Diehl V, et al. J Cancer Res Clin Oncol. 1990;116(1):106-8. doi: 10.1007/BF01612650. J Cancer Res Clin Oncol. 1990. PMID: 1690208 Clinical Trial. No abstract available.

5

Chemotherapy of Hodgkin's lymphoma with alternating cycles of COPP (cyclophosphamide, vincristin, procarbazine, prednisone) and ABVD (doxorubicin, bleomycin, vinblastine and dacarbazine). Results of the HD1 and HD3 trials of the German Hodgkin Study Group.

Diehl V, Pfreundschuh M, Löffler M, Rühl U, Hiller E, Gerhartz H, Wilmanns W, Kirchner H, Schoppe W, Petsch S, et al. Diehl V, et al. Med Oncol Tumor Pharmacother. 1989;6(2):155-62. doi: 10.1007/BF02985239. Med Oncol Tumor Pharmacother. 1989. PMID: 2473363 Clinical Trial.

6

[Therapy of Hodgkin's lymphomas. Results of the German Hodgkin's Disease Study Group].

Pfreundschuh M, Löffler M, Rühl U, Hiller E, Gerhartz H, Wilmanns W, Kirchner H, Schoppe W, Petsch S, Bartels H, et al. Pfreundschuh M, et al. Onkologie. 1988 Feb;11(1):48-52. doi: 10.1159/000216482. Onkologie. 1988. PMID: 2452393 Clinical Trial. German.

7

Cytokine efficiency in the treatment of high-grade malignant non-Hodgkin's lymphomas: results of a randomized double-blind placebo-controlled study with intensified COP-BLAM +/- rhGM-CSF.

Engelhard M, Gerhartz H, Brittinger G, Engert A, Fuchs R, Geiseler B, Gerhartz D, Haunauske AR, Hartlapp HJ, Huhn D, et al. Engelhard M, et al. Ann Oncol. 1994;5 Suppl 2:123-5. doi: 10.1093/annonc/5.suppl_2.s123. Ann Oncol. 1994. PMID: 7515644 Clinical Trial.

8

Recombinant human granulocyte-macrophage colony-stimulating factor as adjunct to chemotherapy in aggressive non-Hodgkin's lymphomas.

Gerhartz HH, Engelhard M, Brittinger G, Schlimok G, Thiel E, Huber C, Emmerich B, Schadek C, Brandmaier R, Stern AC, et al. Gerhartz HH, et al. Semin Oncol. 1994 Dec;21(6 Suppl 16):25-8. Semin Oncol. 1994. PMID: 7528447 Clinical Trial. No abstract available.

9

Treatment of myelodysplastic syndromes (MDS) and high leukaemic risk with low-dose cytosine arabinoside (LD-AraC) plus granulocyte-macrophage colony-stimulating factor (rh GM-CSF). The EORTC Leukaemia Group.

Gerhartz HH, Marcus R, Delmer A, Zwierzina H, de Witte T, Jacobs A, Visiani G, Fiere D, Sonneveld P, Labar B, et al. Gerhartz HH, et al. Infection. 1992;20 Suppl 2:S116-23. doi: 10.1007/BF01705030. Infection. 1992. PMID: 1493935 Clinical Trial.

10

Intervention treatment of established neutropenia with human recombinant granulocyte-macrophage colony-stimulating factor (rhGM-CSF) in patients undergoing cancer chemotherapy.

Gerhartz HH, Stern AC, Wolf-Hornung B, Kazempour M, Schmetzer H, Gugerli U, Jones TC, Wilmanns W. Gerhartz HH, et al. Leuk Res. 1993 Feb;17(2):175-85. doi: 10.1016/0145-2126(93)90063-q. Leuk Res. 1993. PMID: 8429694 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

165 results

Search Page

Filters